跳至主要内容
临床试验/NL-OMON42344
NL-OMON42344招募中不适用

Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation [CEASE AF - Trial] - CEASE-AF

AtriCure Europe B.V.0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with Persistent and Longstanding Persistent Atrial Fibrillation
  • Patient is refractory to or intolerant of at least one antiarrhythmic drug (class I or III)

排除标准

  • 1. Patient has longstanding persistent AF > 10 years
  • 2. Patient presenting with paroxysmal AF
  • 3. Patient with persistent AF and a LA-diameter <= 4cm
  • 4. AF is secondary to electrolyte imbalance, thyroid disease, or other reversible
  • or non-cardiovascular cause

研究者

发起方
AtriCure Europe B.V.

相似试验

Combined Endoscopic Epicardial and Percutaneous... | 临床试验